IMR Press / FBL / Volume 18 / Issue 3 / DOI: 10.2741/4153

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.


PPP3CC feedback regulates IP3-Ca2+ pathway through preventing ITPKC degradation

Show Less
1 State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, 220 Handan Rd., Shanghai 200433, PR China
2 Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University, 197 Rui Jin Er Rd, Shanghai 200025, PR China
3 Department of Thoracic Surgery, Shanghai Pulmonary Hospital of Tongji University,507 Zhengmin Rd., Shanghai 200433, PR China
4 Laboratory of Genetic Medcine and Immunology, Weill Cornell Medical College in Qatar – Qatar Foundation, Education City, P.O.Box 24144, Doha, Qatar
Front. Biosci. (Landmark Ed) 2013, 18(3), 919–927;
Published: 1 June 2013

ITPKC, a susceptibility gene of Kawasaki disease, encodes a kinase that negatively regulates intracellular Ca2+ level and inhibits calcineurin-dependent activation of NFAT by phosphorylating IP3. In this study, we identified a novel ITPKC-interacting protein, namely PPP3CC, using yeast two-hybrid. This interaction was further confirmed by GST pull-down and coimmunoprecipitation assays, and fluorescent microscopy showed co-localization of both proteins in the cell cytoplasm. Our functional studies demonstrated that PPP3CC positively influences the protein level of ITPKC, likely by inhibiting phosphorylation of ITPKC and consequently preventing ITPKC from ubiquitin-mediated protein degradation which requires phosphorylation. Importantly, the protein level of PPP3CC negatively correlates with the cellular level of IP3, suggesting a regulatory role of PPP3CC in the IP3-Ca2+ signaling pathway.

IP3-Ca2+ signal
Kawasaki disease
Protein interaction
Back to top